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Proper functioning of maternal and fetal
hormone and endocrine systems is essential to
ensure a properly developing fetus. Suboptimal
endocrine functioning in utero can have life-
long effects on growth and development
(Fowden and Forhead 2004). Sex hormones,
such as testosterone and estrogen, stimulate
growth in children (Jacklin et al. 1994).
Estrogens are responsible for the female puber-
tal growth spurt and the development of sec-
ondary sex characteristics and have a primary
role in the regulation of bone density, whereas
both estrogens and androgens are important
for growth in boys (Bilezikian 2001; Cutler
1997; Frank 2003). Further, the levels of cir-
culating hormones differ between boys and
girls in the first 6 months of life, suggesting
their early importance in setting up differential
development by sex (Jacklin et al. 1994).
Endocrine function may be altered by
exposure to speciﬁc environmental chemicals,
such as polychlorinated biphenyls (PCBs). As a
class consisting of 209 congeners with various
numbers of chlorine substitutions, PCBs are
persistent environmental pollutants detectable
in nearly all human populations. The degree of
substitution of hydrogen atoms on the
biphenyl ring by larger and negatively charged
chlorine ions creates structurally distinct com-
pounds. PCBs with no substitutions at the
ortho-position (closest to the bond connecting
the two phenyl rings) are coplanar, whereas
those with substitutions become increasingly
noncoplanar. Several reviews suggest that the
planarity in part determines their biologic
effect (Fischer et al. 1998; McKinney and
Waller 1994; Safe 1993).
Evidence suggests that prenatal exposure to
PCBs affects in utero and postnatal growth.
Studies in rhesus monkeys (Allen et al. 1980;
Barsotti and Van Miller 1984) and rats
(Brezner et al. 1984; Overmann et al. 1987)
link prenatal exposure to PCBs with reduced
birth weight. Other animal studies provide evi-
dence of reduced postnatal weight (Morse
et al. 1996) or decreased postnatal weight gain
among offspring of mothers exposed to PCBs
(Bushnell et al. 2002; Faqi et al. 1998; Hany
et al. 1999; Mccoy et al. 1995). Some but not
all epidemiologic research has shown associa-
tions between prenatal PCB exposure and
reduced growth outcomes. Investigations in
Japan and Taiwan into children of mothers
heavily exposed to PCBs and polychlorinated
dibenzofurans found evidence of intrauterine
growth retardation and reduced growth until
school age (Guo et al. 1994; Rogan et al.
1988), with a stronger association among girls
(Guo et al. 1995; Yamashita and Hayashi
1985). Investigations looking at chronic,
lower-dose exposures in Michigan (USA)
(Blanck et al. 2002; Jacobson et al. 1990),
the Netherlands (Patandin et al. 1998), and
Sweden (Mazhitova et al. 1998) found associa-
tions between prenatal or perinatal exposure to
PCBs and reduced growth outcomes at birth
and in early life. However, a prospective inves-
tigation in North Carolina (USA) found no
evidence of an association between PCB expo-
sure and reduced growth through 14 years
(Gladen et al. 2000; Rogan et al. 1986a,
1986b, 1987), and an investigation into prena-
tal exposure to PCBs and other organochlo-
rines in the Ukraine found no effect of
exposure on birth weight (Gladen et al. 2003).
Another study measuring blood organo-
chlorine concentrations in children at 8 years
of age found no association between PCB
levels and height, although it did ﬁnd a dose–
response relationship between exposure to
dichlorodiphenyldichloroethylene (DDE) and
reduced girls’ height (Karmaus et al. 2002).
In this pilot study we extend the previous
investigations by classifying prenatal exposure
to PCBs by their degree of ortho-substitution
and explore the associations between these
categories and childhood growth. Previous
studies either used estimates of contaminated
food consumption as a proxy measure for
PCB exposure (Guo et al. 1994, 1995;
Jacobson et al. 1990; Yoshimura 2003), mea-
sured only a few PCB congeners (Grandjean
et al. 1997; Winneke et al. 1998), or treated
PCBs as a single exposure (Jacobson et al.
1990; Rogan et al. 1986b). To our knowl-
edge, only the Dutch cohort looked at both
congener-specific exposure to PCBs and a
grouped measure of exposure (based on toxic
equivalencies to dioxin) (Patandin et al. 1998;
Schantz et al. 2003). Other studies using con-
gener-specific analysis are ongoing (Schantz
et al. 2003), although to our knowledge none
intends to classify exposure by degree of
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Normal endocrine function in utero and early in childhood influences later height and weight
attainment. Polychlorinated biphenyls (PCBs) are persistent environmental contaminants with
suspected endocrine-disrupting properties. PCBs may mimic or inhibit hormone and endocrine
processes based in part on their structural conﬁguration, with non-ortho-substituted PCBs having
a coplanar orientation and ortho-substituted PCBs becoming increasingly noncoplanar. Coplanar
and noncoplanar PCBs have known differences in biologic effect. Animal studies link prenatal
PCB exposure to adverse birth and early-life growth outcomes, but epidemiologic studies are con-
ﬂicting. We examined whether prenatal exposure to PCBs, categorized by their degree of ortho-
substitution, affected childhood height and weight attainment in 150 children (109 boys and 41
girls) with African-American mothers born at the Columbia-Presbyterian Hospital from 1959
through 1962. Stratifying by sex, we used regression models for repeated measures to investigate
associations between maternal levels of PCBs and height and weight through 17 years of age.
Maternal levels of ortho-substituted PCBs were associated with reduced weight through 17 years
of age among girls but not among boys. Tri-ortho-substituted PCBs were marginally associated
with increased height in boys. Although limited by sample size, our results suggest that prenatal
exposure to PCBs may affect growth, especially in girls, and that ortho-substitution is an impor-
tant determinant of its effect on growth. Key words: adverse effects, cohort studies, environmental
exposure, growth, height, human, polychlorinated biphenyls, prenatal exposure, weight. Environ
Health Perspect 114:779–785 (2006). doi:10.1289/ehp.8488 available via http://dx.doi.org/
[Online 29 December 2005]ortho-substitution. Here, we investigate
whether prenatal exposure to PCBs is associ-
ated with reduced height and weight through
17 years of age. Specifically, we hypothesize
that structural classes of PCBs, based on their
degree of ortho-substitution, will have differ-
ent effects on height and weight attainment,
and that these effects will differ by sex.
Materials and Methods
Study design. The mother–child pairs in this
study represent a subset of the Columbia-
Presbyterian cohort of the National
Collaborative Perinatal Project (NCPP). The
NCPP was initiated > 40 years ago to prospec-
tively investigate the prenatal and familial
antecedents of childhood disorders (Hardy
2003). Detailed information on the sampling
strategy for this subset is provided elsewhere
(Shaffer et al. 1985). Brieﬂy, our subset con-
sists of African-American children born
between 1959 and 1962 whose mothers sup-
plied written informed consent to participate
in a study investigating the association between
the presence of neurologic soft signs (abnormal
motor or sensory function without evidence of
a localized lesion) at 7 years of age and intelli-
gence and psychiatric disorders in late adoles-
cence (Pine et al. 1997; Shaffer et al. 1985).
Sixty-three male and 27 female children with
neurologic soft signs at 7 years of age were
matched to children from the same cohort but
without evidence of soft signs; 162 agreed to
undergo psychiatric assessments at 17 years of
age (Shaffer et al. 1985). Height and weight
measures were taken at birth and 1, 4, 7, and
17 years of age, although the measures at
1 year of age were considered unreliable
because of measurement error and were
excluded from the analysis.
Laboratory analyses. Maternal blood sera
obtained during the third trimester of preg-
nancy and stored at –20°C since collection
(1959–1962) were analyzed for 24 PCB con-
geners, DDE, dichlorodiphenyltrichloroethane
(DDT), and levels of serum cholesterol and
triglycerides. There have been no reported
thaws of the banked sera (Klebanoff M, per-
sonal communication), and organochlorine
degradation under these conditions should be
minimal (Trapp et al. 1984). Because PCBs
have a long half-life in adipose tissue and
because we did not expect levels to vary during
pregnancy (Longnecker et al. 1999), the third-
trimester concentrations were used as an over-
all marker of prenatal exposure.
We conducted PCB assays using routine
methods with the same quality control proce-
dures as previously reported (Gammon et al.
2002) using the method of Brock et al.
(1996). Serum organochlorine levels of 24
PCB congeners (15, 28, 56, 66, 74, 82, 99,
101, 105, 118, 138, 146, 153, 156, 167, 170,
174, 177, 178, 180, 183, 187, 199, 203)
along with p,p´-DDE and p,p´-DDT were
obtained. Detection limits were 0.2 µg/L for
DDE and DDT and 0.07 µg/L for PCB con-
geners. When the serum pool and blanks were
considered together, the limit of detection for
the PCB congeners was 0.01–0.1 µg/L.
Congeners measured below the detection limit
were assigned a value of zero. At least one
PCB was detectable in 100% of our samples,
although not all had detectable levels of every
congener. Two PCB congeners (177 and 178)
had median values below the detection limits,
and one congener (82) is not persistent and
did not give reliable measurements; they were
excluded from analysis, and we report on the
results of the 21 congeners with detectable
concentrations. Serum triglycerides and cho-
lesterol were determined by a commercial lab-
oratory (Nichols Institute/Quest Diagnostics,
Teterboro, NJ). We adjusted for normal
intraindividual variations in serum PCB con-
centrations arising from ﬂuctuations in serum
lipid concentrations by including serum cho-
lesterol and triglyceride concentrations as
independent variables in all statistical analyses
(Koopman-Esseboom et al. 1996).
Of the 162 children in the study, PCB
levels were available for 154. After excluding
twins, our ﬁnal sample size was 150 (109 boys
and 41 girls).
Classification of exposure variables.
Maternal sera PCB concentrations were aggre-
gated into group measures based on the degree
of ortho-substitution of each PCB congener.
We measured concentrations of one non-
ortho-substituted PCB (PCB-15), eight mono-
ortho-substituted PCBs (congeners 28, 56, 66,
74, 105, 118, 156, 167), seven di-ortho-substi-
tuted PCBs (congeners 99, 101, 138, 146,
153, 170, 180), and ﬁve tri-ortho-substituted
PCBs (congeners 174, 183, 187, 199, 203).
We did not measure any non-ortho-substi-
tuted PCBs that are dioxin-like. Exposure to
each of four groupings of PCBs, categorized
by degree of ortho-substitution, was analyzed
in separate models. We performed secondary
analyses using the individual PCB congeners
as the principal exposure variable in separate
regression models.
Selection of potential covariates. We chose
as potential covariates those variables mea-
sured and available in the NCPP ﬁles that are
known or suspected from previous research to
influence the growth of children and that
could plausibly be associated with PCB expo-
sure. These included maternal sera concentra-
tions of DDE, gestational age at birth,
mother’s age at birth, mother’s height and
prepregnancy weight, parity, maternal smok-
ing during pregnancy, breast-feeding (yes/no),
and markers of socioeconomic status, includ-
ing a socioeconomic index, income at regis-
tration, and maternal years of education.
Statistical analyses. We used linear regres-
sion with repeated measures in our primary
analyses. Before conducting these analyses, we
performed separate linear regression analyses
of height and weight at four ages (birth and 4,
Lamb et al.
780 VOLUME 114 | NUMBER 5 | May 2006 • Environmental Health Perspectives
Table 1. Characteristics of the study population compared with the entire Columbia-Presbyterian NCPP
study population.
Columbia-Presbyterian NCPP cohort Our study population
Characteristics (n = 2,177) (n = 150)
Sex (% male) 52 73
Birth weight (g) 3,178 ± 957 3,096 ± 555
Birth length (cm) 50 ± 3.6 50 ± 2.8
Gestational age at delivery (weeks) 39.0 ± 5.3 38.5 ± 3.4
5-Min Apgar score  8.7 ± 1.4 8.5 ± 1.5
Parity 2.1 ± 1.6 2.0 ± 1.5
Maternal age (years) 25.7 ± 5.9 25.9 ± 6.2
Maternal prepregnancy weight (kg) 58.5 ± 10.9 60.8 ± 11.3
Maternal height (cm) 163 ± 15 165 ± 8
Maternal smoking during pregnancy (%) 38 24
Maternal years of education  10.5 ± 2.6 11.4 ± 1.9
Mothers married at registration (%) 88 75
Values are mean ± SD except where otherwise noted.
Table 2. Distribution of maternal PCB concentrations (µg/L).
Percentile distributions
Exposure category No. 25 50 75 Mean ± SD
ΣPCBall
a 150 6.8 8.4 10.4 9.2 ± 3.5
PCB-15 (coplanar) 135 0.5 1.0 1.7 1.2 ± 0.8
ΣPCBmono
b 150 2.3 2.8 3.5 3.1 ± 1.3
ΣPCBdi
c 150 3.0 3.6 5.0 4.2 ± 2.0
ΣPCBtri
d 150 0.5 0.7 1.0 0.8 ± 0.5
Abbreviations: ΣPCBall, sum of all PCBs; ΣPCBdi, sum of di-ortho-substituted PCBs; ΣPCBmono, sum of mono-ortho-substi-
tuted PCBs; ΣPCBtri, sum of tri-ortho-substituted PCBs.
aPCB congeners summed into ΣPCBall: 15, 28, 56, 66, 74, 99, 101, 105, 118, 138, 146, 153, 156, 167, 170, 174, 180, 183, 187, 199,
203. bPCB congeners summed into PCBmono: 28, 56, 66, 74, 105, 118, 156, 167. cPCB congeners summed into PCBdi: 99, 101,
138, 146, 153, 170, 180. dPCB congeners summed into PCBtr: 174, 183, 187, 199, 203.7, and 17 years of age) to assess whether any
association between exposure and outcome
was limited to a specific time point. Height
and weight were modeled separately, instead
of with a grouped measure such as body mass
index, to investigate whether PCB exposure
inﬂuences height and weight differently. We
performed separate analyses for each of the
four grouped measures of PCB concentrations
classiﬁed by degree of ortho-substitution. We
then used linear regression with repeated mea-
sures to describe the association between
maternal concentrations of PCBs, grouped by
degree of ortho-substitution, and child’s height
and weight through 17 years of age. We used
generalized estimating equations (Liang and
Zeger 1986; Zeger and Liang 1986) to esti-
mate regression parameters, which modeled
the overall association between PCB exposure
during pregnancy and postnatal height and
weight, accounting for within-subject correla-
tion. Regressions with repeated measures were
performed both including and excluding data
from 17 years of age to assess the associations
between prenatal PCB exposure and height
and weight before and after the onset of
puberty. In an additional set of analyses to dis-
cern associations between concentrations of
individual PCB congeners and height and
weight, we performed repeated-measures lin-
ear regressions using maternal concentrations
of individual PCB congeners as exposure
measures, standardized to a mean of zero and
a standard deviation of one.
To satisfy the statistical requirements of the
models, we applied logarithm transformations
to all outcome variables to stabilize their vari-
ances. Predictor variables (including the PCB
measures, serum triglyceride and cholesterol,
and maternal height and weight) with skewed
distributions were also log-transformed. For all
regression analyses, the basic model included
the PCB variable of interest as well as serum
cholesterol and triglyceride levels. Covariates
associated with the outcomes that changed esti-
mate of the regression coefﬁcient of the PCB
variable on any of the height and weight out-
comes by > 50% of a SE were included in the
ﬁnal regression model. Mother’s prepregnancy
weight, preterm delivery, and mother’s height
(for the children’s height regression analyses)
were retained in ﬁnal models. The presence of
neurologic soft signs at 7 years of age—the
original selection factor for the cohort under
investigation—did not change the regression
parameter estimates or their precision and was
therefore not included in the ﬁnal models. In
addition, blood concentrations of DDE,
although correlated with PCB levels, were not
associated with the outcome measures under
investigation and therefore did not inﬂuence
the magnitude of the PCB–height or
PCB–weight association obtained through
regression analyses.
Results
Table 1 shows baseline characteristics of our
study sample and those of the entire Columbia-
Presbyterian NCPP cohort. Our sample was
similar to the Columbia-Presbyterian NCPP
cohort with respect to a variety of characteristics
thought or suspected to influence childhood
growth, including gestational age at delivery,
mother’s age, mother’s height and weight, and
birth weight. There were proportionately more
boys in our sample (73%) than in the overall
Columbia-Presbyterian NCPP cohort (52%)
because of higher prevalence of neurologic soft
signs in boys.
Table 2 provides the distribution of mater-
nal concentrations of PCBs in our sample, and
Table 3 provides baseline characteristics of the
study population stratiﬁed by quartiles of total
maternal PCB concentrations. As expected,
older mothers had higher concentrations of
PCBs, reflecting cumulative exposure with
age. Most other baseline variables were similar
among the exposure categorizations.
Regression analyses. Table 4 presents the
regression coefficients and 95% confidence
intervals (CIs) from the “age-speciﬁc” analyses
modeling the association between maternal lev-
els of PCBs and weight (or height) separately
for each measured time point, whereas Table 5
presents the same results from the repeated
measures analyses. The regression coefﬁcients
in Table 4 correspond to the unit change in
the natural log of weight (grams) or height
(centimeters) at each age corresponding to a
one-unit change in the natural log of maternal
PCB concentration (micrograms per liter).
Table 5 presents the estimated regression coef-
ficients and 95% CIs from the repeated-
measures analyses modeling the association
between maternal levels of PCBs and weight
(or height) measured at birth and at 4, 7, and
17 years of age. The regression coefﬁcient (b)
in Table 5 was related to the quantity (0.693b)
that corresponds to the average change in the
natural log of weight (grams) [or height (cen-
timeters)] at each age used in the analysis for a
doubling of maternal PCB concentrations.
Girls’ weight. Concentrations of ortho-
substituted PCBs were associated with
reduced girls’ weight, particularly at 4 and 7
years of age, with no observable pattern in the
magnitude of association between groups with
different degrees of ortho-substitution (Table
4). In contrast, the non-dioxin-like non-ortho-
substituted PCB-15 was not associated with
Prenatal PCB exposure and childhood growth
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Table 3. Baseline and outcome characteristics by quartile group of total PCB exposure.
Quartile groups of total PCB exposure
Quartile group [µg/L (mean PCB level)] 1 (5.8) 2 (7.7) 3 (9.4) 4 (13.8)
Total sample (n = 150)
Birth weight (g) 3,202 ± 578 3,010 ± 551 3,033 ± 477 3,129 ± 615
Birth length (cm) 50.0 ± 2.5 49.3 ± 3.4 49.1 ± 2.5 49.6 ± 2.9
Gestational age at delivery (weeks) 39.2 ± 2.6 38.6 ± 3.6 37.9 ± 4.0 38.5 ± 3.2
Parity 1.7 ± 1.2 1.9 ± 1.3 2.6 ± 2.0 1.8 ± 1.1
Maternal age (years) 23.9 ± 6.1 25.6 ± 6.1 26.5 ± 6.2 27.6 ± 6.1
Maternal prepregnancy weight (lbs) 138 ± 30 132 ± 26 139 ± 26 128 ± 17
Maternal height (in) 64 ± 3 65 ± 3 65 ± 2 64 ± 2
Maternal smoking during pregnancy (%) 41 43 41 42
Maternal years of education 11.4 ± 1.4 11.6 ± 1.9 10.9 ± 2.5 11.3 ± 2.1
Family income at registration ($) 4,019 ± 1,673 4,379 ± 2,261 5,067 ± 2,373 5,719 ± 2,624
Socioeconomic index at registration  59.8 ± 19.2 51.3 ± 21.6 54.3 ± 18.3 55.5 ± 15.4
Girls (n = 41)
Birth weight (g) 3,050 ± 786 3,064 ± 470 3,070 ± 403 3,082 ± 499
Birth length (cm) 49.3 ± 3.2 49.0 ± 2.0 49.0 ± 2.7 49.3 ± 2.2
Gestational age at delivery (weeks) 38.5 ± 3.2 38.7 ± 2.8 39.3 ± 1.5 39.0 ± 0.9
Parity 2.0 ± 1.0 2.0 ± 1.8 3.4 ± 3.0 2.1 ± 0.9
Maternal age (years) 27.3 ± 7.0 25.8 ± 7.5 29.9 ± 6.1 29.3 ± 5.6
Maternal prepregnancy weight (lbs) 139 ± 23 135 ± 22 150 ± 30 132 ± 10
Maternal height (in) 64 ± 2 66 ± 2 65 ± 2 64 ± 2
Maternal smoking during pregnancy (%) 30 36 71 30
Maternal years of education  12.3 ± 1.4 11.4 ± 2.4 10.9 ± 1.7 11.0 ± 2.5
Family income at registration ($) 4,333 ± 1,472 4,722 ± 2,539 5,278 ± 1,394 5,398 ± 2,619
Socioeconomic index at registration  48.4 ± 16.7 48.9 ± 25.0 55.6 ± 20.1 54.1 ± 19.6
Boys (n = 109)
Birth weight (g) 3,256 ± 440 3,035 ± 623 2,898 ± 589 3,195 ± 579
Birth length (cm) 50.2 ± 2.0 49.9 ± 4.0 48.6 ± 3.2 50.0 ± 2.6
Gestational age at delivery (weeks) 39.3 ± 2.0 39.0 ± 4.4 36.7 ± 4.7 38.6 ± 3.0
Parity 1.5 ± 1.2 1.6 ± 0.9 2.2 ± 1.3 1.6 ± 1.2
Maternal age (years) 22.2 ± 5.2 25.1 ± 5.3 26.3 ± 6.9 27.2 ± 6.1
Maternal prepregnancy weight (kg) 60.3 ± 15.0 59.9 ± 15.2 63.0 ± 11.3 58.1± 8.2
Maternal height (cm) 163 ± 8 163 ± 8 165 ± 5 165 ± 5
Maternal smoking during pregnancy (%) 42 48 36 48
Maternal years of education 11.2 ± 1.3 11.7 ± 1.6 10.9 ± 2.8 11.5 ± 1.9
Family income at registration ($) 3,929 ± 1,748 4,250 ± 2,192 4,976 ± 2,713 5,848 ± 2,673
Socioeconomic index at registration  50.2 ± 20.2 52.4 ± 20.2 53.7 ± 18.0 56.0 ± 13.7
Values are mean ± SD except where otherwise noted.girls’ weight at any measured time point. To
put the magnitude of the regression coefﬁcients
in perspective, a doubling of maternal levels of
mono-ortho-substituted PCBs was associated
with an 11% reduction in weight measured at
4 and 7 years, after adjustment for maternal
prepregnancy weight, preterm status, and
serum cholesterol and triglyceride levels. The
magnitude of association was similar, but
slightly less, when using the exposure groups
with greater degrees of ortho-substitution.
Repeated-measures analyses of the rela-
tionship between maternal concentrations of
PCBs and girls’ weight through 17 years of
age showed that concentrations of ortho-
substituted PCBs were associated with
reduced girls’ weight through 17 years of age,
whereas the non-ortho-substituted PCB was
not associated with girls’ weight (Table 5).
Boys’ weight. Maternal levels of di-ortho-
substituted PCBs were marginally associated
with increased boys’ weight at 4 but not at 7
years of age (Table 4). No other categorizations
were associated with boys’ weight, although the
direction of the regression coefficients was
opposite that found in the girls’ analyses. The
magnitudes of the estimated regression coefﬁ-
cients were small compared with those
observed among girls and not appreciably dif-
ferent from zero in most situations.
Repeated-measures analysis through 17
years of age showed no association between
PCB exposure and boys’ weight (Table 5).
Girls’ height. Maternal concentrations of
the non-dioxin-like, non-ortho-substituted
PCB (PCB-15) were associated with increased
girls’ height at 4, 7, and 17 years of age,
whereas exposure to ortho-substituted PCBs
was not associated with girls’ height (Table
4). Among girls, a doubling of maternal con-
centrations of the coplanar PCB-15 was asso-
ciated with a 2% increase in height at 4 and
7 years of age.
When the data were analyzed using linear
models with repeated measures through 17
years of age, similar patterns were found (Table
5). In particular, the non-ortho-substituted
PCB-15 was associated with increased girls’
height through 17 years of age, whereas the
summed measure of mono-ortho-substituted
PCBs was inversely, but nonsigniﬁcantly, asso-
ciated with girls’ height. No associations were
found when using the higher-ortho-substituted
summary measures or the overall sum of PCBs
as the exposure variable.
Boys’ height. Boys’ height was not associ-
ated with maternal PCB concentrations at
any of the time points measured (Table 4).
The direction of the regression coefficients
was opposite that seen in the girls’ analyses,
although their magnitudes were not apprecia-
bly different from zero. When the data were
analyzed using linear regression with repeated
measures through 17 years of age, exposure to
tri-ortho-substituted PCBs was associated with
a small increase in height, with no other expo-
sure categorizations showing an association.
Secondary analyses. We conducted a sec-
ondary repeated-measures analysis excluding
from the model data at 17 years of age to
investigate associations before the onset of
puberty. This created marginally stronger-
magnitude associations between exposure to
ortho-substituted PCBs and girls’ weight (data
not shown). This was expected because the
strongest associations between PCB exposure
and outcome occurred at 4 and 7 years of age.
No other results were substantially changed.
To assess whether speciﬁc PCB congeners
had a large inﬂuence on height or weight, we
performed separate repeated-measures analy-
ses for the 21 PCB congeners. Figure 1A pre-
sents the results of the congener-speciﬁc linear
regression analyses using weight as the out-
come. Fifteen of 20 ortho-substituted PCBs
were significantly associated with reduced
weight through 17 years of age in girls. In
contrast, among boys, none of the PCB con-
geners was signiﬁcantly associated with weight
through 17 years of age, and nearly all had a
different direction of association than was
found among girls.
Reduced girls’ height was associated with
exposure to four of the eight measured mono-
ortho-substituted PCBs and one of the seven
di-ortho-substituted PCBs but not to higher-
ortho-substituted PCBs (Figure 1B). Increased
girls’ height was associated with exposure to
the non-dioxin-like but coplanar PCB-15 and
Lamb et al.
782 VOLUME 114 | NUMBER 5 | May 2006 • Environmental Health Perspectives
Table 4. Results of simple linear regression: weight and height versus prenatal PCB exposure, by sex.a
Weight [parameter estimate (95% CI)]b Height [parameter estimate (95% CI)]b
Exposurec Birth 4 years 7 years 17 years Birth 4 years 7 years 17 years 
Girls
PCB-15 0.07 (–0.03 to 0.17) 0.01 (–0.06 to 0.08) –0.03 (–0.11 to 0.06) –0.01 (–0.12 to 0.09) 0.02 (–0.01 to 0.05) 0.02 (0.01 to 0.04) 0.02 (0.00 to 0.04) 0.02 (0.00 to 0.04)
(coplanar)
ΣPCBmono –0.16 (–0.31 to –0.01) –0.17 (–0.26 to –0.07) –0.16 (–0.31 to –0.02) –0.11 (–0.27 to 0.06) –0.04 (–0.08 to 0.01) –0.01 (–0.04 to 0.03) –0.01 (–0.05 to 0.02) –0.02 (–0.06 to 0.01)
ΣPCBdi –0.09 (–0.22 to 0.05) –0.15 (–0.23 to –0.06) –0.15 (–0.27 to –0.03) –0.06 (–0.20 to 0.08) –0.01 (–0.05 to 0.03) 0.00 (–0.04 to 0.03) –0.01 (–0.04 to 0.02) –0.02 (–0.05 to 0.01)
ΣPCBtri –0.03 (–0.15 to 0.08) –0.12 (–0.19 to –0.05) –0.15 (–0.25 to –0.05) –0.08 (–0.18 to 0.03) 0.00 (–0.04 to 0.03) 0.00 (–0.03 to 0.02) –0.02 (–0.04 to 0.01) –0.02 (–0.04 to 0.01)
ΣPCBall –0.09 (–0.26 to 0.08) –0.18 (–0.28 to –0.07) –0.20 (–0.35 to –0.04) –0.10 (–0.27 to 0.07) –0.02 (–0.06 to 0.03) 0.01 (–0.03 to 0.05) 0.00 (–0.04 to 0.04) –0.02 (–0.06 to 0.02)
Boys
PCB-15 0.00 (–0.03 to 0.02)b 0.01 (–0.01 to 0.03) 0.01 (–0.02 to 0.03) 0.02 (–0.01 to 0.05) 0.00 (–0.01 to 0.01) 0.00 (0.00 to 0.00) 0.00 (0.00 to 0.01) 0.00 (0.00 to 0.01)
(coplanar)
ΣPCBmono 0.02 (–0.07 to 0.11) 0.02 (–0.05 to 0.09) 0.01 (–0.08 to 0.09) –0.03 (–0.16 to 0.10) 0.00 (–0.02 to 0.03) –0.01 (–0.03 to 0.02) 0.01 (–0.01 to 0.02) 0.00 (–0.02 to 0.03)
ΣPCBdi 0.03 (–0.05 to 0.12) 0.06 (0.00 to 0.13) 0.05 (–0.03 to 0.13) 0.00 (–0.12 to 0.12) 0.00 (–0.02 to 0.03) 0.01 (–0.02 to 0.03) 0.01 (–0.01 to 0.03) 0.00 (–0.02 to 0.03)
ΣPCBtri 0.01 (–0.05 to 0.07) 0.03 (–0.02 to 0.08) 0.02 (–0.04 to 0.07) –0.02 (–0.10 to 0.07) 0.00 (–0.02 to 0.02) 0.01 (0.00 to 0.03) 0.01 (0.00 to 0.02) 0.01 (–0.01 to 0.02)
ΣPCBall 0.00 (–0.10 to 0.10) 0.04 (–0.03 to 0.12) 0.03 (–0.06 to 0.12) –0.02 (–0.16 to 0.13) 0.00 (–0.06 to 0.03) 0.01 (–0.03 to 0.05) 0.00 (–0.04 to 0.04) –0.02 (–0.06 to 0.02)
Abbreviations: ΣPCBall, sum of all PCBs; ΣPCBdi, sum of di-ortho-substituted PCBs; ΣPCBmono, sum of mono-ortho-substituted PCBs; ΣPCBtri, sum of tri-ortho-substituted PCBs. 
aParameter estimates for the log-transformed PCB measure, adjusted for maternal prepregnancy weight, preterm status, and serum triglyceride and cholesterol. Models with height as
the outcome were also adjusted for maternal height. bHeight and weight measures were log-transformed; regression parameters present the unit change in ln[weight (g)] or ln[height
(cm)] for a one-unit change in ln[PCB (µg/L)]. cAll PCB exposure measures were summed by structural categorization (non-, mono-, di-, or tri-ortho-substituted, or sum of all PCB mea-
sures) and then log-transformed. 
Table 5. Estimated coefficients (95% CIs) for regression models with repeated measures: birth and 4, 7,
and 17 years of age.
Outcomea
Exposureb Girls’ weight Girls’ height Boys’ weight Boys’ height
PCB-15 (coplanar) 1.1 (–5.9 to 8.1) 1.9 (–0.0 to 3.8) 0.7 (–1.1 to 2.4) 0.2 (–0.4 to 0.7)
ΣPCBmono –13.7 (–20.8 to –6.6) –1.8 (–4.2 to 0.6) 0.6 (–4.9 to 6.0) 0.0 (–1.7 to 1.8)
ΣPCBdi –10.6 (–18.2 to –3.0) –1.1 (–3.5 to 1.4) 3.7 (–1.6 to 9.0) 0.6 (–0.9 to 2.1)
ΣPCBtri –9.2 (–15.0 to –3.3) –1.0 (–3.1 to 1.2) 1.8 (–2.0 to 5.6) 1.2 (0.1 to 2.2)
ΣPCBall –13.2 (–20.7 to –5.7) –0.6 (–3.2 to 2.0) 1.7 (–4.7 to 8.1) 0.5 (–1.4 to 2.3)
Abbreviations: ΣPCBall, sum of all PCBs; ΣPCBdi, sum of di-ortho-substituted PCBs; ΣPCBmono, sum of mono-ortho-substi-
tuted PCBs; ΣPCBtri, sum of tri-ortho-substituted PCBs. Data are 100 × the parameter estimates for the log-transformed
PCB measure, adjusted for maternal prepregnancy weight, preterm status, and serum triglyceride and cholesterol.
Models with height as the outcome were also adjusted for maternal height.
aHeight and weight measures were log-transformed. bAll PCB exposure measures were summed by structural catego-
rization and then log-transformed. the mono-ortho-substituted PCB-28. In con-
trast, exposure to one di-ortho-substituted and
two tri-ortho-substituted PCBs was marginally
associated with increased height among boys.
This analysis did not have sufﬁcient power to
discern whether the magnitudes of associations
were signiﬁcantly different among congeners
having the same degree of ortho-substitution.
Additional analyses investigated the
robustness of the results. First, as noted
above, the cohort from which this sample was
derived was originally selected on the basis of
the presence of neurologic soft signs at 7 years
of age. Adding an indicator variable for the
presence or absence of soft signs to the regres-
sion models did not change the results.
Second, we conducted a post hoc analysis to
assess whether including the 12-month height
and weight measures (which were excluded
from primary analyses) inﬂuenced the results.
Including this time point did not influence
the magnitude or precision of the repeated-
measures analyses (data not shown).
Discussion
Prenatal exposure to ortho-substituted PCBs
during pregnancy was associated with reduced
girls’ but not boys’ weight up to 17 years of age
in this study. Associations between prenatal
PCB exposure and height were less consistent,
with exposure to the only measured non-ortho-
substituted PCB associated with increased
height among girls, and exposure to tri-ortho-
substituted PCB levels associated with
increased height through 17 years of age
among boys, although the small magnitude of
this association questions the relevance of this
ﬁnding. The potential for PCBs to inﬂuence
growth differentially by sex needs to be further
investigated in studies with larger sample sizes
to statistically test for potential sex interactions.
Our ﬁndings are in general agreement with
some, but not all, previous epidemiologic stud-
ies. PCB exposure was more strongly associated
with reduced growth among girls in the
Japanese and Taiwan cohorts (Guo et al. 1994,
1995; Rogan et al. 1988; Yamashita and
Hayashi 1985) as well as the Michigan cohort
(Blanck et al. 2002; Jacobson et al. 1990). Our
findings differ from those reported in the
North Carolina study, which found no evi-
dence of an association between prenatal PCB
exposure and height or weight through 14 years
of age (Gladen et al. 2000), and from those
reported by Karmaus et al. (2002), which
found reductions in girls’ growth through
8 years of age associated with childhood expo-
sure to DDE but not to PCBs. Possible reasons
for the divergence between this study and those
cited here may center on differences in exposure
and population characteristics. Our study mea-
sured prenatal exposure to PCBs in an urban
population with a low prevalence of ever breast-
feeding (16%), whereas the North Carolina
study population had a much higher level of
ever breast-feeding (89%) (Rogan and Gladen
1991), and the measures in the Karmaus et al.
(2002) study were taken at 8 years of age. It is
possible that prenatal exposures to PCBs have
different effects on growth than do childhood
exposures or exposures via breast-feeding. For
example, investigations in a Dutch cohort
found an association between prenatal PCB
exposure and growth rate through 3 months of
age among formula-fed but not breast-fed
infants, which the authors speculated may be
due in part to the beneﬁcial effects of breast-
feeding acting to counter the putative effects of
PCB exposure (Patandin et al. 1999). Our
study is the first to examine the association
between prenatal PCB exposure and height and
weight through 17 years of age.
We chose not to categorize the PCBs
available using toxic equivalency factors
Prenatal PCB exposure and childhood growth
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Figure 1. Congener-speciﬁc repeated measures regression: weight (g) (A) and height (cm) (B) through age 17 years of age vs. prenatal PCB exposure (µg/L).
aBeta coefﬁcients and 95% CIs are obtained after standardizing the PCB measure to a mean of 0 and standard deviation of 1. bWeight and PCB measures were log-transformed, such
that the beta coefﬁcients correspond to the change in the natural log of weight (g) associated with a standard deviation increase in the natural log of the PCB measure, adjusted for
mother’s prepregnancy weight, preterm delivery, and serum cholesterol and triglyeride levels. cHeight and PCB measures were log-transformed, such that the beta coefﬁcients corre-
spond to the change in the natural log of height (cm) associated with a standard deviation increase in the natural log of the PCB measure, adjusted for mother’s prepregnancy weight
and height, preterm delivery, and serum cholesterol and triglyceride levels. 
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PCB-187(TEFs) (Van den Berg et al. 1998), as has
been done in previous analyses (e.g., Patandin
et al. 1998). First, the TEFs of PCBs are
based on their relative “dioxin-like” binding
affinity to the aryl hydrocarbon receptor
(AhR). Our hypothesis was that PCBs might
influence height or weight through mecha-
nisms other than an AhR-mediated one.
Second, of the PCBs measured in our analy-
sis, only four have an assigned TEF based on
dioxin-like activity (Van den Berg et al.
1998). These PCBs (congeners 105, 118,
156, 167) have very low dioxin-like activity,
with the TEFs ranging from 0.00001 (PCB-
167) to 0.0005 (PCB-156). Because our
a priori hypothesis was focused on a non-
dioxin-like effect of PCBs based on structure,
we felt that a classification scheme based on
structure was appropriate.
Our study has potential limitations. First,
the sample size was relatively small. However,
we found evidence of an association between
prenatal exposure to ortho-substituted PCBs
and girls’ weight despite the small sample size.
This strengthens the evidence of a true associ-
ation between these variables. We had more
than twice as many boys as girls in our sample
and found little evidence of an association
between maternal PCB levels and boys’
weight. The results of the height analyses,
which showed some evidence of a positive
effect of exposure to some tri-ortho-substi-
tuted PCBs on boys’ height, were also limited
because of sample size.
Our ability to measure speciﬁc PCB con-
geners led to the potential problem of multiple
statistical tests, which may increase the chance
of a type I error. However, our analysis is con-
cerned primarily with the grouped measures of
exposure based on the degree of ortho-substitu-
tion. Thus, rather than attempting to look at
the statistical signiﬁcance of every analysis per-
formed, more can be gained by looking for pat-
terns. The facts that the direction of association
was consistently different between boys and
girls and that the association with weight was
consistently stronger than with height provide
support that the associations observed here were
not simply due to multiple comparisons.
Height and weight measurements were
also subject to measurement error. Evidence
in the NCPP data ﬁles from which the height
and weight measures were obtained showed
that the weight measurement at 17 years of
age may have slight errors due to an improp-
erly functioning scale. Because of this, the sec-
ondary analyses excluding 17 years of age data
from the repeated-measures analysis served
the dual purposes of eliminating the error-
prone 17-year measures as well as confining
our height and weight analysis to prepubertal
age points. Differences between the analyses
including and excluding the 17-year measures
were discussed, and the interpretation of the
results does not change in any material way
after exclusion of the 17-year measures. There
is no reason to suspect that these measure-
ment errors were differential based on expo-
sure or outcome status.
Although the NCPP data files contain
extensive information on many variables
thought to be associated with childhood
growth, it is of course not exhaustive. We had
no information among the individuals in this
study on age at puberty, which could be useful
as an outcome for further study. We also did
not have information on speciﬁc measures of
growth (e.g., leg growth, whose growth spurt
occurs predominantly before puberty), which
precluded us from assessing speciﬁc aspects of
growth that may have been affected by prenatal
exposure to PCBs. Further, we also did not
have sufﬁcient sera available to measure levels of
other environmental contaminants, such as
dioxin-like PCBs, dioxin, lead, or mercury.
Because of this, we are unable to rule out the
possibility that the associations seen in this
study are due partly to confounding by these
other environmental contaminants. However,
because exposure to ortho-substituted PCBs was
associated with weight but not height, and in
girls but not boys, such unmeasured confound-
ing would have to operate only among girls and
only for weight to explain these results.
Our underlying hypothesis is a biologic
one: that prenatal exposure to speciﬁc types of
PCBs adversely affects endocrine systems in
children, which can then lead to reductions in
height and weight. If one of the causal mecha-
nisms through which PCB exposure acts is via
interference with normal sex hormone
processes, then a ﬁnding speciﬁc to girls would
not be unexpected. Our analysis could not dis-
cern whether different degrees of ortho-substi-
tution were more associated with reduced
weight measures. The results of the analyses
using height as the outcome are more equivo-
cal and have a much smaller magnitude of
association than that seen for the weight
analyses. The only non-ortho-substituted PCB
measured in this analysis was associated with
increased height measures among girls,
whereas certain mono-ortho-substituted PCBs
were associated with decreased height, and the
higher-ortho-substituted PCBs showed no
association with girls’ height. Among boys,
certain tri-ortho-substituted PCBs were associ-
ated with increased height, whereas most were
not associated with height. The lack of a clear
trend of association, as was seen in the weight
analyses, places interpretations from the height
analyses as speculative.
These findings, limited by measurement
error and a small sample size, suggest an inter-
esting direction for future research. Animal
and laboratory evidence strongly suggests that
the structure of PCB congeners determines
their biologic effect. This study provides
evidence that ortho-substituted PCBs are
associated with reduced weight in girls but not
in boys. Further studies are needed to clarify
this relationship.
REFERENCES
Allen JR, Barsotti DA, Carstens LA. 1980. Residual effects of
polychlorinated biphenyls on adult nonhuman primates
and their offspring. J Toxicol Environ Health 6:55–66.
Barsotti DA, Van Miller JP. 1984. Accumulation of a commercial
polychlorinated biphenyl mixture (Aroclor 1016) in adult rhe-
sus monkeys and their nursing infants. Toxicology 30:31–44.
Bilezikian JP. 2001. The role of estrogens in male skeletal
development. Reprod Fertil Dev 13:253–259.
Blanck HM, Marcus M, Rubin C, Tolbert PE, Hertzberg VS,
Henderson AK, et al. 2002. Growth in girls exposed
in utero and postnatally to polybrominated biphenyls and
polychlorinated biphenyls. Epidemiology 13:205–210.
Brezner E, Terkel J, Perry AS. 1984. The effect of aroclor 1254
(PCB) on the physiology of reproduction in the female
rat—I. Comp Biochem Physiol C 77:65–70.
Brock JW, Burse VW, Ashley DL, Najam AR, Green VE, Korver
MP, et al. 1996. An improved analysis for chlorinated pesti-
cides and polychlorinated biphenyls (PCBs) in human and
bovine sera using solid-phase extraction. J Anal Toxicol
20:528–536.
Bushnell PJ, Moser VC, MacPhail RC, Oshiro WM, Derr-Yellin
EC, Phillips PM, et al. 2002. Neurobehavioral assessments
of rats perinatally exposed to a commercial mixture of
polychlorinated biphenyls. Toxicol Sci 68:109–120.
Cutler GB Jr. 1997. The role of estrogen in bone growth and
maturation during childhood and adolescence. J Steroid
Biochem Mol Biol. 61:141–144.
Faqi AS, Dalsenter PR, Merker HJ, Chahoud I. 1998. Effects on
developmental landmarks and reproductive capability of
3,3‘,4,4‘-tetrachlorobiphenyl and 3,3‘,4,4‘,5-pentacholoro-
biphenyl in offspring of rats exposed during pregnancy.
Hum Exp Toxicol 17:365–372.
Fischer LJ, Seegal RF, Ganey PE, Pessah IN, Kodavanti PRS.
1998. Symposium overview: toxicity of non-coplanar PCBs.
Toxicol Sci 41:49–61.
Fowden AL, Forhead AJ. 2004. Endocrine mechanisms of
intrauterine programming. Reproduction 127:515–526.
Frank GR. 2003. Role of estrogen and androgen in pubertal
skeletal physiology. Med Pediatr Oncol 41:217–221.
Gammon MD, Wolff MS, Neugut AI, Eng SM, Teitelbaum SL,
Britton JA, et al. 2002. Environmental toxins and breast
cancer on Long Island. II. Organochlorine compound levels
in blood. Cancer Epidemiol Biomarkers Prev 11:686–697.
Gladen BC, Ragan NB, Rogan WJ. 2000. Pubertal growth and
development and prenatal and lactational exposure to
polychlorinated biphenyls and dichlorodiphenyl
dichloroethene. J Pediatr 136:490–496.
Gladen BC, Shkiryak-Nyzhnyk ZA, Chyslovska N, Zadorozhnaja
TD, Little RE. 2003. Persistent organochlorine compounds
and birth weight. Ann Epidemiol 13:151–157.
Grandjean P, Weihe P, White RF, Debes F, Araki S, Yokoyama K,
et al. 1997. Cognitive deﬁcit in 7-year-old children with pre-
natal exposure to methylmercury. Neurotoxicol Teratol
19:417–428.
Guo YL, Lambert GH, Hsu CC. 1995. Growth abnormalities in the
population exposed in utero and early postnatally to poly-
chlorinated biphenyls and dibenzofurans. Environ Health
Perspect 103(suppl 6):117–122.
Guo YL, Lin CJ, Yao WJ, Ryan JJ, Hsu CC. 1994. Musculo-
skeletal changes in children prenatally exposed to poly-
chlorinated biphenyls and related compounds (yu-cheng
children). J Toxicol Environ Health 41:83–93.
Hany J, Lilienthal H, Sarasin A, Roth-Harer A, Fastabend A,
Dunemann L, et al. 1999. Developmental exposure of rats to a
reconstituted PCB mixture or Aroclor 1254: effects on organ
weights, aromatase activity, sex hormone levels, and sweet
preference behavior. Toxicol Appl Pharmacol 158:231–243.
Hardy JB. 2003. The Collaborative Perinatal Project: lessons
and legacy. Ann Epidemiol 13:303–311.
Jacklin CN, McBride C, McCrory P, Gallahan L. 1994. Neonatal
sex-steroid hormones and physical size at four years.
J Pediatr Endocrinol 7:253–259.
Jacobson JL, Jacobson SW, Humphrey HEB. 1990. Effects of
exposure to PCBs and related-compounds on growth and
activity in children. Neurotoxicol Teratol 12:319–326.
Lamb et al.
784 VOLUME 114 | NUMBER 5 | May 2006 • Environmental Health PerspectivesKarmaus W, Asakevich S, Indurkhya A, Witten J, Kruse H. 2002.
Childhood growth and exposure to dichlorodiphenyl
dichloroethene and polychlorinated biphenyls. J Pediatr
140:33–39.
Koopman-Esseboom C, Weisglas-Kuperus N, de Ridder MA,
van der Paauw CG, Tuinstra LG, Sauer PJ. 1996. Effects of
polychlorinated biphenyl/dioxin exposure and feeding type
on infants’ mental and psychomotor development.
Pediatrics 97:700–706.
Liang KY, Zeger SL. 1986. Longitudinal data-analysis using gen-
eralized linear-models. Biometrika 73:13–22.
Longnecker MP, Klebanoff MA, Gladen BC, Berendes HW.
1999. Serial levels of serum organochlorines during preg-
nancy and postpartum. Arch Environ Health 54:110–114.
Mazhitova Z, Jensen S, Ritzen M, Zetterstrom R. 1998.
Chlorinated contaminants, growth and thyroid function in
schoolchildren from the Aral Sea region in Kazakhstan.
Acta Paediatr 87:991–995.
Mccoy G, Finlay MF, Rhone A, James K, Cobb GP. 1995.
Chronic polychlorinated-biphenyls exposure on 3 genera-
tions of oldﬁeld mice (Peromyscus polionotus)—effects on
reproduction, growth, and body residues. Arch Environ
Contam Toxicol 28:431–435.
McKinney JD, Waller CL. 1994. Polychlorinated-biphenyls as
hormonally active structural analogs. Environ Health
Perspect 102:290–297.
Morse DC, Plug A, Wesseling W, van den Berg KJ, Brouwer A.
1996. Persistent alterations in regional brain glial ﬁbrillary
acidic protein and synaptophysin levels following pre- and
postnatal polychlorinated biphenyl exposure. Toxicol Appl
Pharmacol 139:252–261.
Overmann SR, Kostas J, Wilson LR, Shain W, Bush B. 1987.
Neurobehavioral and somatic effects of perinatal PCB
exposure in rats. Environ Res 44:56–70.
Patandin S, Koopman-Esseboom C, de Ridder MA, Weisglas-
Kuperus N, Sauer PJ. 1998. Effects of environmental expo-
sure to polychlorinated biphenyls and dioxins on birth size
and growth in Dutch children. Pediatr Res 44:538–545.
Patandin S, Lanting CI, Mulder PG, Boersma ER, Sauer PJ,
Weisglas-Kuperus N. 1999. Effects of environmental expo-
sure to polychlorinated biphenyls and dioxins on cognitive
abilities in Dutch children at 42 months of age. J Pediatr
134:33–41.
Pine DS, Shaffer D, Schonfeld IS, Davies M. 1997. Minor physi-
cal anomalies: modiﬁers of environmental risks for psychi-
atric impairment? J Am Acad Child Adolesc Psychiatr
36:395–403.
Rogan WJ, Gladen BC. 1991. PCBs, DDE, and child develop-
ment at 18 and 24 months. Ann Epidemiol 1(5):407–413.
Rogan WJ, Gladen BC, Hung KL, Koong SL, Shih LY, Taylor JS,
et al. 1988. Congenital poisoning by polychlorinated
biphenyls and their contaminants in Taiwan. Science
241:334–336.
Rogan WJ, Gladen BC, McKinney JD, Carreras N, Hardy P,
Thullen J, et al. 1986a. Polychlorinated biphenyls (PCBs)
and dichlorodiphenyl dichloroethene (DDE) in human milk:
effects of maternal factors and previous lactation. Am J
Public Health 76:172–177.
Rogan WJ, Gladen BC, McKinney JD, Carreras N, Hardy P,
Thullen J, et al. 1986b. Neonatal effects of transplacental
exposure to PCBs and DDE. J Pediatr 109:335–341.
Rogan WJ, Gladen BC, McKinney JD, Carreras N, Hardy P,
Thullen J, et al. 1987. Polychlorinated biphenyls (PCBs)
and dichlorodiphenyl dichloroethene (DDE) in human milk:
effects on growth, morbidity, and duration of lactation. Am
J Public Health 77:1294–1297.
Safe S. 1993. Toxicology, structure-function relationship, and
human and environmental-health impacts of polychlori-
nated-biphenyls—progress and problems. Environ Health
Perspect 100:259–268.
Schantz SL, Widholm JJ, Rice DC. 2003. Effects of PCB expo-
sure on neuropsychological function in children. Environ
Health Perspect 111:357–376.
Shaffer D, Schonfeld I, O’Connor PA, Stokman C, Trautman P,
Shafer S, et al. 1985. Neurological soft signs—their rela-
tionship to psychiatric-disorder and intelligence in child-
hood and adolescence. Arch Gen Psychiatr 42:342–351.
Trapp M, Baukloh V, Bohnet HG, Heeschen W. 1984. Pollutants
in human follicular ﬂuid. Fertil Steril 42:146–148.
Van den Berg M, Birnbaum L, Bosveld AT, Brunstrom B,
Cook P, Feeley M, et al. 1998. Toxic equivalency factors
(TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife.
Environ Health Perspect 106:775–792.
Winneke G, Bucholski A, Heinzow B, Kramer U, Schmidt E,
Walkowiak J, et al. 1998. Developmental neurotoxicity of
polychlorinated biphenyls (PCBS): cognitive and psy-
chomotor functions in 7-month old children. Toxicol Lett
102–103:423–428.
Yamashita F, Hayashi M. 1985. Fetal PCB syndrome: clinical
features, intrauterine growth retardation and possible
alteration in calcium metabolism. Environ Health Perspect
59:41–45.
Yoshimura T. 2003. Yusho in Japan. Ind Health 41:139–148.
Zeger SL, Liang KY. 1986. Longitudinal data-analysis for dis-
crete and continuous outcomes. Biometrics 42:121–130.
Prenatal PCB exposure and childhood growth
Environmental Health Perspectives • VOLUME 114 | NUMBER 5 | May 2006 785